Food, Drugs, Healthcare, Life Sciences

Chemical Regulation. Chemical regulation in the personal care industry is expanding, with significant developments such as Washington State's HB 1047, the Toxic-Free Cosmetics Act. Starting Jan. 1, 2025.

On January 6, 2025, the U.S. Food and Drug Administration ("FDA") and the Office for Human Research Protections ("OHRP") issued a joint draft guidance on including...

7538 Sayılı Sosyal Sigortalar ve Genel Sağlık Sigortası Kanunu ile Bazı Kanunlarda Değişiklik Yapılmasına Dair Kanun" 15.01.2025 tarihli 32783 sayılı Resmî Gazete'de yayımlanmıştır.

Chemical Regulation. Chemical regulation in the personal care industry is expanding, with significant developments such as Washington State's HB 1047, the Toxic-Free Cosmetics Act. Starting Jan. 1, 2025.

On January 6, 2025, the U.S. Food and Drug Administration ("FDA") and the Office for Human Research Protections ("OHRP") issued a joint draft guidance on including...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between brand-name drugmakers and generics.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

Chemical Regulation. Chemical regulation in the personal care industry is expanding, with significant developments such as Washington State's HB 1047, the Toxic-Free Cosmetics Act. Starting Jan. 1, 2025.

On January 6, 2025, the U.S. Food and Drug Administration ("FDA") and the Office for Human Research Protections ("OHRP") issued a joint draft guidance on including...

A little over two years ago, the Modernization of Cosmetic Regulation Act (MoCRA) was (at long last) enacted. The passing of the law which, among other...